Back to search

The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas1

Data up to Jan 2025

Published2006
Citations113
References20

Total Citations Per Year

Abstract

References (20)

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2005 • 18,835 citations

Prediction of Creatinine Clearance from Serum Creatinine

1976 • 15,066 citations

Drug-Induced Thrombocytopenia

1998 • 483 citations

Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

2004 • 259 citations

Determination of Ideal Body Weight for Drug Dosage Calculations

1983 • 212 citations

Chemoimmunotherapy of Disseminated Malignant Melanoma with Dimethyl Triazeno Imidazole Carboxamide and Bacillus Calmette-Guérin

1974 • 197 citations

Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme

2004 • 136 citations

Results with methyl-CCNU and DTIC in metastatic melanoma

1977 • 99 citations

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group

2004 • 91 citations

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

2005 • 78 citations

The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma

1999 • 69 citations

Phase I clinical trial of mitozolomide.

1985 • 50 citations

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma

2005 • 49 citations

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group

2004 • 27 citations

Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): Report of a Phase II trial

2005 • 20 citations

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC

2005 • 15 citations

Clinical comparison of adriamycin and a combination of methyl‐CCNU and imidazole carboxamide in disseminated malignant melanoma

1976 • 15 citations

Phase I study of mitozolomide on a once daily for 5 days schedule

1990 • 7 citations

Phase Ii Trial of Mitozolomide in Patients with Advanced Ovarian Cancer: A Study of the Eortc Gynecological Cancer Cooperative Group

1989 • 7 citations

Polychemotherapie des metastasierenden Melanoms

1976 • 6 citations

Cited By (0)

Loading...
The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults… (2006) – Neuro-Oncology | Metascience Observatory Explorer